Related Experiment Video

Updated: Dec 9, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.9K

Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies

Emanuele Monda1, Giuseppe Palmiero1, Marta Rubino1

  • 1Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.

International Journal of Molecular Sciences
|September 9, 2020
PubMed

Insights

Inflammation and immune system activation are key in cardiomyopathies (CMPs), a group of heart muscle diseases. Understanding these roles may lead to targeted anti-inflammatory treatments for better CMP management.

Area of Science:

  • Cardiology
  • Immunology
  • Genetics

Background:

  • Cardiomyopathies (CMPs) are diverse heart muscle diseases with varied phenotypes.
  • Genetic mutations (sarcomeric and non-sarcomeric) and epigenetic/environmental factors influence CMPs.
  • Inflammation is increasingly recognized as a critical factor in CMP pathogenesis.

Purpose of the Study:

  • To review current knowledge on inflammation's role in CMPs.
  • To examine immune system activation in CMP development.
  • To identify molecular targets for anti-inflammatory therapies in CMPs.

Main Methods:

  • Literature review of studies on inflammation and CMPs.
  • Analysis of immune system pathways implicated in myocardial diseases.
  • Identification of potential therapeutic targets based on reviewed evidence.

Main Results:

  • Inflammation and immune responses are significant contributors to CMP pathogenesis.
  • Specific inflammatory pathways and immune cells are involved in myocardial damage.
  • Evidence suggests a strong link between immune dysregulation and CMP progression.

Conclusions:

  • Inflammation and immune activation are central to the pathogenesis of cardiomyopathies.
  • Targeting inflammatory pathways offers a promising strategy for novel CMP treatments.
  • Further research into molecular targets could enable personalized anti-inflammatory therapies for CMP patients.

Keywords:
cardiomyopathiesinflammationpathogenesis

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.4K
Isolation of Functional Cardiac Immune Cells07:26

Isolation of Functional Cardiac Immune Cells

Published on: December 5, 2011

15.4K

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
227
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
146
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
350
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
280
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
95
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K